Antibiotic susceptibility and resistance genes in Escherichia coli from broilers reared in a low-antibiotic-use production system

Antimicrobial resistance (AMR) is a major global concern for animal and human health. This study investigated the occurrence and patterns of AMR in Escherichia coli (E. coli) isolated from Swedish broiler flocks reared under low-antibiotic-use conditions. During routine necropsy examinations of 80 broilers from 40 flocks with increased mortality associated with colibacillosis, liver samples were collected for bacteriological analysis. E. coli isolated from the liver were classified as clinical E. coli. In addition, boot sock samples were taken to collect feces from the litter of 60 broiler flocks with no signs of disease or increased mortality. E. coli isolates (n = 109) obtained from boot sock samples were classified as non-clinical E. coli. Susceptibility to 15 antibiotics was assessed using broth microdilution, and resistance-associated genes and mutations were identified through whole-genome sequencing (WGS). Overall resistance was low, with all isolates susceptible to 9 of the 15 tested antibiotics: meropenem, azithromycin, amikacin, gentamicin, tigecycline, ceftazidime, cefotaxime, chloramphenicol, and colistin. Resistance was significantly more frequent in non-clinical than clinical isolates for the six antibiotics with detected resistance (P < 0.05) and was strongly correlated with the presence of known AMR genes or mutations. Among clinical isolates, 93.7% were fully susceptible to all tested antibiotics, compared with 49.5% of non-clinical isolates. The highest resistance rates were observed in non-clinical isolates against ampicillin (34%), sulfamethoxazole (32.1%), and trimethoprim (28.4%). The results of this study indicate that in low-antibiotic-use production systems, factors beyond direct antibiotic use-such as horizontal gene transfer, vertical transmission, and environmental contamination-may contribute to AMR dissemination. Higher AMR rates in non-clinical isolates suggest that these isolates may serve as reservoirs of resistance genes. This highlights the importance of monitoring commensal E. coli and farm environments to support AMR mitigation and sustainable broiler production.

Authors

Institutions

Publication Details

Journal
Poultry Science
Published
2026-03-12
DOI
https://doi.org/10.1016/j.psj.2026.106764
Primary Topic
Pharmaceutical and Antibiotic Environmental Impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antibiotic susceptibility and resistance genes in Escherichia coli from broilers reared in a low-antibiotic-use production system

Désirée S. Jansson, Homayoon Davam, I. Hansson, Jesper Rydèn et al.
Poultry Science
Pharmaceutical and Antibiotic Environmental Impacts
article

Antibiotic susceptibility and resistance genes in Escherichia coli from broilers reared in a low-antibiotic-use production system

Désirée S. Jansson, Homayoon Davam, I. Hansson, Jesper Rydèn, Emma Nord
article en

Abstract

Antimicrobial resistance (AMR) is a major global concern for animal and human health. This study investigated the occurrence and patterns of AMR in Escherichia coli (E. coli) isolated from Swedish broiler flocks reared under low-antibiotic-use conditions. During routine necropsy examinations of 80 broilers from 40 flocks with increased mortality associated with colibacillosis, liver samples were collected for bacteriological analysis. E. coli isolated from the liver were classified as clinical E. coli. In addition, boot sock samples were taken to collect feces from the litter of 60 broiler flocks with no signs of disease or increased mortality. E. coli isolates (n = 109) obtained from boot sock samples were classified as non-clinical E. coli. Susceptibility to 15 antibiotics was assessed using broth microdilution, and resistance-associated genes and mutations were identified through whole-genome sequencing (WGS). Overall resistance was low, with all isolates susceptible to 9 of the 15 tested antibiotics: meropenem, azithromycin, amikacin, gentamicin, tigecycline, ceftazidime, cefotaxime, chloramphenicol, and colistin. Resistance was significantly more frequent in non-clinical than clinical isolates for the six antibiotics with detected resistance (P < 0.05) and was strongly correlated with the presence of known AMR genes or mutations. Among clinical isolates, 93.7% were fully susceptible to all tested antibiotics, compared with 49.5% of non-clinical isolates. The highest resistance rates were observed in non-clinical isolates against ampicillin (34%), sulfamethoxazole (32.1%), and trimethoprim (28.4%). The results of this study indicate that in low-antibiotic-use production systems, factors beyond direct antibiotic use-such as horizontal gene transfer, vertical transmission, and environmental contamination-may contribute to AMR dissemination. Higher AMR rates in non-clinical isolates suggest that these isolates may serve as reservoirs of resistance genes. This highlights the importance of monitoring commensal E. coli and farm environments to support AMR mitigation and sustainable broiler production.

Poultry ScienceVol. 105(6)
Swedish University of Agricultural Sciences (SE)
Zero hunger
Openalex Percentile: Top 28%
Pharmaceutical and Antibiotic Environmental Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.